Skip to main content
. 2018 Apr 30;16(2):315–318. doi: 10.5217/ir.2018.16.2.315

Table 1. Baseline Characteristics of the Study Patients.

Variable Value (n=10)
Age (yr) 52.9±9.6
Male sex 5 (50.0)
Time since diagnosis (yr) 7.2±5.9
Ulcer location
 Terminal ileum 2 (20.0)
 IC valve 5 (50.0)
 Colon 1 (10.0)
 Anastomosis site 2 (20.0)
Deep ulcer (vs. shallow ulcer) 6 (60.0)
Volcano ulcer (vs. oval ulcer) 3 (30.0)
Ulcer size (cm)
 1–2 4 (40.0)
 2–3 1 (10.0)
 ≥3 5 (50.0)
No. of surgery 1.4±2.3
No. of perforation 0.8±1.0
Extraintestinal manifestation
 Oral ulceration 10 (100.0)
 Genital ulceration 4 (40.0)
 Uveitis 1 (10.0)
 Skin lesion 6 (60.0)
 Arthritis 7 (70.0)
 Nervous system 0
 Vascular system 0
Previous medication
 Thiopurine 7 (70.0)
 Anti-TNF-α
  Infliximab 3 (30.0)
  Adalimumab 2 (20.0)
  Infliximab, adalimumab 1 (10.0)
DAIBD total score 82.5±36.8
CRP level (mg/L) 57.8±36.0
ESR level (mm/hr) 38.0±36.1

Values are presented as mean±SD or number (%).

IC, ileocecal; TNF, tumor necrosis factor; DAIBD, disease activity index for intestinal Behçet's disease.